This brand name is authorized in Nigeria.
The drug P-ALAXIN contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
6A9O50735X - ARTENIMOL
|
Artemisinin is used in the treatment of malaria due to species Plasmodium. |
|
2
|
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-100810 | Tablet | P-ALAXIN DS TABLET TAB 80 mg; 640 mg 10 x 1 x 6 | 64 NF-PP-408941 P-ALAXIN DS TABLET DIHYDROARTEMISININ 80MG & PIPERAQUINE PHOSPHATE 640MG DIHYDROARTEMISININ 80MG & PIPERAQUINE PHOSPHATE 640MG, PREGELATINISED STARCH BP 219.1MG, MALTODEXRIN BP 40MG, CROSCARMELLOSE SODIUM BP 80.12MG, MAGNESIUM STERATE BP 10.76MG, WINCOAT WT-01215 BLUE IH 36MG, ISOPROPYL ALCOHOL BP, DICHLOROMETHANE BP, PURIFIED TALC BP A4-100810 Drugs Imported Products 10 x 1 x 6 Over The Counter (OTC) GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com BLISS GVS PHARMA LIMITED, PLOT NO 10, 11-A,12, SURVEY NO 38/1, DEWAN UDYOG NAGAR, ALIYALI VILLAGE, MAHARASHTRA STATE,INDIA, India | 30/04/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
P01BF05 | Artenimol and piperaquine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-100810 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.